- Home
- SOPH vs SXTC Comparison
SOPH vs SXTC Comparison
Compare SOPH & SXTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOPH
- SXTC
- Stock Information
- Founded
- SOPH 2011
- SXTC 2005
- Country
- SOPH Switzerland
- SXTC China
- Employees
- SOPH N/A
- SXTC 75
- Industry
- SOPH Biotechnology: Biological Products (No Diagnostic Substances)
- SXTC Biotechnology: Pharmaceutical Preparations
- Sector
- SOPH Health Care
- SXTC Health Care
- Exchange
- SOPH Nasdaq
- SXTC Nasdaq
- Market Cap
- SOPH 214.9M
- SXTC 185.6M
- IPO Year
- SOPH 2021
- SXTC 2019
- Fundamental
- Price
- SOPH $3.46
- SXTC $1.60
- Analyst Decision
- SOPH Buy
- SXTC
- Analyst Count
- SOPH 1
- SXTC 0
- Target Price
- SOPH $7.00
- SXTC N/A
- AVG Volume (30 Days)
- SOPH 88.9K
- SXTC 72.0K
- Earning Date
- SOPH 08-05-2025
- SXTC 01-01-0001
- Dividend Yield
- SOPH N/A
- SXTC N/A
- EPS Growth
- SOPH N/A
- SXTC N/A
- EPS
- SOPH N/A
- SXTC N/A
- Revenue
- SOPH $69,688,000.00
- SXTC $1,740,907.00
- Revenue This Year
- SOPH $16.13
- SXTC N/A
- Revenue Next Year
- SOPH $23.80
- SXTC N/A
- P/E Ratio
- SOPH N/A
- SXTC N/A
- Revenue Growth
- SOPH 7.32
- SXTC N/A
- 52 Week Low
- SOPH $2.58
- SXTC $0.95
- 52 Week High
- SOPH $4.92
- SXTC $8.48
- Technical
- Relative Strength Index (RSI)
- SOPH 56.10
- SXTC 48.26
- Support Level
- SOPH $2.96
- SXTC $1.55
- Resistance Level
- SOPH $3.24
- SXTC $1.66
- Average True Range (ATR)
- SOPH 0.26
- SXTC 0.10
- MACD
- SOPH -0.00
- SXTC 0.01
- Stochastic Oscillator
- SOPH 84.53
- SXTC 45.83
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
About SXTC China SXT Pharmaceuticals Inc.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.